allylamine - CISMeF

Preferred Label : allylamine;

MeSH definition : Possesses an unusual and selective cytotoxicity for VASCULAR SMOOTH MUSCLE cells in dogs and rats. Useful for experiments dealing with arterial injury, myocardial fibrosis or cardiac decompensation.;

MeSH synonym : 3 aminopropylene; 3-aminopropylene;

MeSH CAS label : 2-Propen-1-amine;

MeSH Related Number : 107-11-9 (Allylamine);

Registry Number MeSH : 107-11-9;

Wikipedia link : https://en.wikipedia.org/wiki/Allylamine;

Codes EINECS : 203-463-9;

Is substance : O;

UNII : 48G762T011;

InChIKey : VVJKKWFAADXIJK-UHFFFAOYSA-N;

Details

Origin ID

D000499;

UMLS CUI

C0002157;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- allylamine [Substance BNPC]
Record concept(s)
- allylamine [MeSH concept]
Related MeSH Supplementary Concept(s)
- (S)-N-(alpha-methylbenzyl)allylamine [MeSH Supplementary Concept]
- 2-(3,4-dimethoxyphenyl)-3-fluoroallylamine [MeSH Supplementary Concept]
- 3-(4'-bromo-(1,1'-biphenyl)-4-yl)-3-(4-phenyl)-N,N-dimethyl-2-propen-1-amine [MeSH Supplementary Concept]
- 3-(4'-bromo-(1,1'-biphenyl)-4-yl)-3--(4-bromophenyl)-N,N-dimethyl-2-propen-1-amine [MeSH Supplementary Concept]
- 3-fluoro-2-(4-methoxybenzyl)allylamine [MeSH Supplementary Concept]
- GT 16-239 [MeSH Supplementary Concept]
- MDL 72638 [MeSH Supplementary Concept]
- N,N-dimethyl-3,3-diphenyl-1-methylallylamine [MeSH Supplementary Concept]
- N,N-dimethylallylamine [MeSH Supplementary Concept]
- N-Boc-N-(p-methoxyphenyl)-3-cyclohexylallylamine [MeSH Supplementary Concept]
- PXS-4728A [MeSH Supplementary Concept]
- allyl(6-(3-(4-bromophenyl)benzo(d)isothiazol-6-yloxy)hexyl)methylamine [MeSH Supplementary Concept]
- aquopentanamine cobalt(III) [MeSH Supplementary Concept]
- ketobemidone, N,N-dimethyl-3,3-diphenyl-1-methylallylamine drug combination [MeSH Supplementary Concept]
- naftifine [MeSH Supplementary Concept]
- poly(acrylic acid)-poly(allylamine hydrochloride) [MeSH Supplementary Concept]
- poly(allylamine-cyanocinnamylideneacetate) [MeSH Supplementary Concept]
- poly(allylbiguanido-co-allylamine) [MeSH Supplementary Concept]
- triallylamine [MeSH Supplementary Concept]
Semantic type(s)
- Hazardous or Poisonous Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- allylamine [Substance BNPC]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients